When was GSK founded?

GSK was founded in 1715 and raised its 1st funding round 293 years after it was founded.

Where is GSK located?

GSK is headquartered in London, United Kingdom. It is registered at GSK House, Dr Annie Besant Road worli, Mumbai City, Mumbai, Maharashtra, India, 400030.

Who is the current CEO of GSK?

Dame Emma Walmsley and Luke Miels s of GSK.

Which legal entities is GSK associated with?

GSK is associated with GSK PLC and 6 others.

How many employees does GSK have?

As of Jun 30, 2026, the latest employee count at GSK is 92091.

Is GSK a funded company?

GSK is a funded company, having raised an undisclosed amount across 28 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 16, 2008.

How much is GSK worth?

The last known valuation of GSK was $***** as of Dec 03, 2018.

When was the latest funding round of GSK?

GSK's latest funding was a $***** Grant (prize money) round on Sep 23, 2025, with participation from 1 investor.

What is the annual revenue of GSK?

Annual revenue of GSK is more than £1B as on Dec 31, 2025

Where does GSK rank among its competitors?

GSK ranks 47th amongst 1703 active competitors, of which 84 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was GSK, which secured $2.43M in Sep, 2025.

Who are the top competitors of GSK?

GSK's top competitors include AbbVie, Amgen and Gilead. Among them, GSK secured the most recent funding round in September, 2025.

GSK - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is GSK an acquired company?

GSK got acquired by Unilever on Dec 03, 2018.

Company Details

Manufacturer of pharmaceutical medicines and vaccines for human health conditions. Research and development efforts focus on respiratory, immunology, inflammation, oncology, and infectious diseases. Operations include the discovery, development, and production of therapeutic treatments and preventative vaccines. Products are distributed to address various medical needs and health threats.

Website: www.gsk.com/en-gb/
Social
Phone Number: +44 **********
Registered Address: GSK House, Dr Annie Besant Road worli, Mumbai City, Mumbai, Maharashtra, India, 400030

Key Metrics

Founded Year

1715

Location

London, United Kingdom

Stage

Acquired

Latest Funding Round

Grant (prize money), Sep 23, 2025, $*****

Last Known Valuation

$***** as on Dec 03, 2018

Investors

Elliott Management & 17 more

Ranked

47^th among 1703 active competitors

Annual Revenue

£1B+ as on Dec 31, 2025

Employee Count

92,091 as on Jun 30, 2026

Investment & Acquisitions

Nuvalent & 65 more

Similar Companies

AbbVie & 1730 more

Exit Details

Acquired by Unilever (Dec 03, 2018)

View GSK's full profile

GSK is associated with 7 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED CIN: L24239MH1924PLC001151 , India, Active	Nov 13, 1924	₹1,000+ Cr (As on Mar 31, 2025)	452 (As on May 31, 2025)
GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED CIN: L24231PB1958PLC002257 , India, Amalgamated	Oct 30, 1958	₹1,000+ Cr (As on Mar 31, 2019)	-
BIDDLE SAWYER LIMITED CIN: U51900MH1948PLC006218 , India, Active	Mar 13, 1948	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
HALEON INDIA CONSUMER HEALTH PRIVATE LIMITED CIN: U24232PB2014FTC039082 , India, Active	Dec 04, 2014	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	991 (As on May 01, 2026)
GSK INDIA GLOBAL SERVICES PRIVATE LIMITED CIN: U74999KA2020FTC135154 , India, Active	Jun 23, 2020	₹1,000+ Cr (As on Mar 31, 2025)	2743 (As on Jan 31, 2025)
GLAXOSMITHKLINE ASIA PRIVATE LIMITED CIN: U15209DL1995PTC073278 , India, Inactive for e-filing	Oct 18, 1995	₹1,000+ Cr (As on Mar 31, 2022)	1407 (As on Aug 01, 2025)
GSK PLC CIN: 3888792 , United Kingdom, Active	Dec 05, 1999	£1B+ (As on Dec 31, 2025)	69305 (As on Dec 31, 2024)

GSK got acquired by Unilever on Dec 03, 2018 at an acquisition amount of $*****.

Click here to take a look at GSK's acquisition in detail

GSK has raised funding over 28 rounds. Its first funding round was on Jul 16, 2008. Its latest funding round was a Grant (prize money) round on Sep 23, 2025 for $*****. 1 investor participated in its latest round. GSK has 18 institutional investors.

Here is the list of recent funding rounds of GSK:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 23, 2025	8517251	Grant (prize money)	8491629	8754173	1298703	8746208
Dec 29, 2023	1258929	Grant (prize money)	6120048	8112732	9327221	Economy And Finance
Nov 24, 2023	7354413	Grant (prize money)	8719009	4701274	5131616	Economy And Finance

Access funding benchmarks and valuations. Sign up today!

View details of GSK's funding rounds and investors

Here are the details of GSK's key team members:

Dame Emma Walmsley: CEO of GSK. They serve on the board of 1 company.
Contact Info: 1 email address
Luke Miels: CEO of GSK.
Contact Info: 1 email address

GSK's Board of Directors

GSK's board has 12 active members. Julie Brown and Dame Emma Walmsley are part of team and Dr Harry Dietz, Dr Vishal Sikka, Elizabeth Mckee Anderson, Dr Anne Beal, Jonathan Richard Symonds, Dr Hal Barron, Wendy Mira Becker, Dr Jeannie Tsun-huei Lee, Gavin Robert Screaton and Charles Bancroft are independent board members.

Here is the list of GSK's board of directors:

Name	Type	Representing	Status	Duration
dadc{hs	Team	-	Current	4y 1m
ossbkth	Team	-	Current	8y 5m
Dr Harry Dietz	Independent board member	-	Current	4y 6m
flixtjw	Independent board member	-	Current	5y 9m
pxagzob	Independent board member	-	Current	1y 8m
wijsdpe	Independent board member	-	Current	1y 2m
utcwfhg	Independent board member	-	Current	3y 5m
bjxaqxb	Independent board member	-	Current	5y 4m
{walixj	Independent board member	-	Current	6y 2m
uiahipk	Independent board member	-	Current	8y 8m
{qgobpk	Independent board member	-	Current	6y 5m
rorqtmx	Independent board member	-	Current	3y 8m

View details of GSK's Founder profiles and Board Members

GSK's employee count trend

GSK has 92,091 employees as of Jun 26. Here is GSK's employee count trend over the years:

Uncover GSK's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GSK include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of GSK, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Alcor Fund, Berkshire Hathaway & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	Jindal ventures, Menlo Ventures & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	79/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	76/100
6th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	73/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	72/100
8th	Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public	Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others	-	Gershon Capital, Kaccelerator & 7 others	71/100
9th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
10th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, Triodos Investment Management ... & 11 others	70/100
47th	GSK 1715, London (United Kingdom), Acquired	Manufacturer of pharmaceutical medicines and vaccines for human health conditions	-	Elliott Management, Digital Pharma Lab & 16 others	57/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on GSK's competitors? Click here to see the top ones

GSK has made 42 investments in companies including Ouro Medicines and Relation. GSK has also acquired 24 companies including Nuvalent and 35Pharma.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 09, 2026	Acquisition	Nuvalent	2017	Cambridge (United States)
Feb 25, 2026	Acquisition	35Pharma	2021	Montreal (Canada)
Jan 20, 2026	Acquisition	RAPT	2015	San Francisco (United States)